Percutaneous treatment of coronary subclavian steal syndrome

Niall T Mulvihill1, Mohamed Loutfi, Emmanuel Salengro

  • 1Unite de Cardiologie Interventionelle, Clinique Pasteur, Toulouse, France. mulvihn@tcd.ie

Insights

Coronary subclavian steal syndrome, a complication of internal mammary artery grafts, causes coronary ischemia due to subclavian artery stenosis. Percutaneous treatment offers excellent immediate and long-term results for this condition.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Vascular Surgery

Background:

  • Coronary subclavian steal syndrome (CSSS) is a rare complication following coronary artery bypass grafting (CABG) using internal mammary artery (IMA) grafts.
  • It is characterized by reversed flow in the IMA graft due to proximal subclavian artery stenosis, leading to myocardial ischemia.

Purpose of the Study:

  • To describe the pathophysiology and clinical presentation of CSSS.
  • To evaluate the efficacy and safety of percutaneous intervention for treating CSSS.

Main Methods:

  • Review of relevant literature and case studies.
  • Analysis of percutaneous techniques, including angioplasty and stenting of the subclavian artery.
  • Assessment of immediate and long-term outcomes.

Main Results:

  • CSSS can manifest with diverse symptoms, including angina and graft failure.
  • Percutaneous transluminal angioplasty and stenting of the stenotic subclavian artery effectively restore antegrade flow.
  • High technical success rates and significant improvement in clinical symptoms are observed post-intervention.

Conclusions:

  • Percutaneous revascularization is a safe and effective treatment option for CSSS.
  • Intervention restores graft perfusion and alleviates ischemic symptoms, offering excellent long-term outcomes.
  • Early diagnosis and treatment are crucial for managing this complication.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...